BackIsland Pharmaceuticals Limited Overview

Island Pharmaceuticals Limited Current Cash

Latest current cash for ILA.AX: $13M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$12.87M
↑ 77.49% YoYΔ $5.62M vs prior year quarter

Peer trimmed avg / median

Loading

Island Pharmaceuticals Limited Current Cash History

Loading

Island Pharmaceuticals Limited vs. peers: Current Cash Comparison

Loading

Island Pharmaceuticals Limited Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Island Pharmaceuticals Limited (ILA.AX) FAQ

Island Pharmaceuticals Limited posts a current cash of $13M as of June 2026. That compares with $7.3M in the prior-year period — up 77.5% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Island Pharmaceuticals Limited's current cash was $7.3M. The latest reading is $13M — a 77.5% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Current Cash is one piece of Island Pharmaceuticals Limited's financial statement story. At $13M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for ILA.AX's current cash usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Island Pharmaceuticals Limited's other metric pages and overview cover the third.

Judging Island Pharmaceuticals Limited against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in current cash easier to interpret. Start with $13M here, then scan peer and history charts to see if the gap is persistent.